146 related articles for article (PubMed ID: 32062662)
1. Metabolic Acidosis Alters Expression of Slc22 Transporters in Mouse Kidney.
Gottier Nwafor J; Nowik M; Anzai N; Endou H; Wagner CA
Kidney Blood Press Res; 2020; 45(2):263-274. PubMed ID: 32062662
[TBL] [Abstract][Full Text] [Related]
2. [Mangiferin promotes uric acid excretion and kidney function improvement and modulates related renal transporters in hyperuricemic mice].
Hu QH; Zhang X; Wang Y; Kong LD
Yao Xue Xue Bao; 2010 Oct; 45(10):1239-46. PubMed ID: 21348301
[TBL] [Abstract][Full Text] [Related]
3. The SLC22 Transporter Family: A Paradigm for the Impact of Drug Transporters on Metabolic Pathways, Signaling, and Disease.
Nigam SK
Annu Rev Pharmacol Toxicol; 2018 Jan; 58():663-687. PubMed ID: 29309257
[TBL] [Abstract][Full Text] [Related]
4. SLC22 Transporters in the Fly Renal System Regulate Response to Oxidative Stress In Vivo.
Zhang P; Azad P; Engelhart DC; Haddad GG; Nigam SK
Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948211
[TBL] [Abstract][Full Text] [Related]
5. Organic Anion Transporters (OAT) and Other SLC22 Transporters in Progression of Renal Cell Carcinoma.
Whisenant TC; Nigam SK
Cancers (Basel); 2022 Sep; 14(19):. PubMed ID: 36230695
[TBL] [Abstract][Full Text] [Related]
6. Analyses of coding region polymorphisms in apical and basolateral human organic anion transporter (OAT) genes [OAT1 (NKT), OAT2, OAT3, OAT4, URAT (RST)].
Xu G; Bhatnagar V; Wen G; Hamilton BA; Eraly SA; Nigam SK
Kidney Int; 2005 Oct; 68(4):1491-9. PubMed ID: 16164626
[TBL] [Abstract][Full Text] [Related]
7. Expression of basolateral organic anion and cation transporters in experimental cadmium nephrotoxicity in rat kidney.
Ljubojević M; Breljak D; Herak-Kramberger CM; Anzai N; Sabolić I
Arch Toxicol; 2016 Mar; 90(3):525-41. PubMed ID: 25588984
[TBL] [Abstract][Full Text] [Related]
8. Multiple organic anion transporters contribute to net renal excretion of uric acid.
Eraly SA; Vallon V; Rieg T; Gangoiti JA; Wikoff WR; Siuzdak G; Barshop BA; Nigam SK
Physiol Genomics; 2008 Apr; 33(2):180-92. PubMed ID: 18270321
[TBL] [Abstract][Full Text] [Related]
9. Evolutionary Analysis and Classification of OATs, OCTs, OCTNs, and Other SLC22 Transporters: Structure-Function Implications and Analysis of Sequence Motifs.
Zhu C; Nigam KB; Date RC; Bush KT; Springer SA; Saier MH; Wu W; Nigam SK
PLoS One; 2015; 10(11):e0140569. PubMed ID: 26536134
[TBL] [Abstract][Full Text] [Related]
10. Betaine reduces serum uric acid levels and improves kidney function in hyperuricemic mice.
Liu YL; Pan Y; Wang X; Fan CY; Zhu Q; Li JM; Wang SJ; Kong LD
Planta Med; 2014 Jan; 80(1):39-47. PubMed ID: 24338552
[TBL] [Abstract][Full Text] [Related]
11. Changes of drug pharmacokinetics mediated by downregulation of kidney organic cation transporters Mate1 and Oct2 in a rat model of hyperuricemia.
Nishizawa K; Yoda N; Morokado F; Komori H; Nakanishi T; Tamai I
PLoS One; 2019; 14(4):e0214862. PubMed ID: 30951542
[TBL] [Abstract][Full Text] [Related]
12. Antihyperuricemic and nephroprotective effects of resveratrol and its analogues in hyperuricemic mice.
Shi YW; Wang CP; Liu L; Liu YL; Wang X; Hong Y; Li Z; Kong LD
Mol Nutr Food Res; 2012 Sep; 56(9):1433-44. PubMed ID: 22865646
[TBL] [Abstract][Full Text] [Related]
13. Renal uptake of substrates for organic anion transporters Oat1 and Oat3 and organic cation transporters Oct1 and Oct2 is altered in rats with adenine-induced chronic renal failure.
Komazawa H; Yamaguchi H; Hidaka K; Ogura J; Kobayashi M; Iseki K
J Pharm Sci; 2013 Mar; 102(3):1086-94. PubMed ID: 23280877
[TBL] [Abstract][Full Text] [Related]
14. Cell free expression and functional reconstitution of eukaryotic drug transporters.
Keller T; Schwarz D; Bernhard F; Dötsch V; Hunte C; Gorboulev V; Koepsell H
Biochemistry; 2008 Apr; 47(15):4552-64. PubMed ID: 18361503
[TBL] [Abstract][Full Text] [Related]
15. Urate Transporter URAT1 in Hyperuricemia: New Insights from Hyperuricemic Models.
Li X; Yan Z; Tian J; Zhang X; Han H; Ye F
Ann Clin Lab Sci; 2019 Nov; 49(6):756-762. PubMed ID: 31882426
[TBL] [Abstract][Full Text] [Related]
16. Organic anion and cation SLC22 "drug" transporter (Oat1, Oat3, and Oct1) regulation during development and maturation of the kidney proximal tubule.
Gallegos TF; Martovetsky G; Kouznetsova V; Bush KT; Nigam SK
PLoS One; 2012; 7(7):e40796. PubMed ID: 22808265
[TBL] [Abstract][Full Text] [Related]
17. SGLT2 inhibition and renal urate excretion: role of luminal glucose, GLUT9, and URAT1.
Novikov A; Fu Y; Huang W; Freeman B; Patel R; van Ginkel C; Koepsell H; Busslinger M; Onishi A; Nespoux J; Vallon V
Am J Physiol Renal Physiol; 2019 Jan; 316(1):F173-F185. PubMed ID: 30427222
[TBL] [Abstract][Full Text] [Related]
18. Pathophysiological regulation of renal SLC22A organic ion transporters in acute kidney injury: pharmacological and toxicological implications.
Saito H
Pharmacol Ther; 2010 Jan; 125(1):79-91. PubMed ID: 19837111
[TBL] [Abstract][Full Text] [Related]
19.
Yee SW; Giacomini KM
Drug Metab Dispos; 2021 Dec; 50(9):1193-210. PubMed ID: 34921098
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological Evaluation of Dotinurad, a Selective Urate Reabsorption Inhibitor.
Taniguchi T; Ashizawa N; Matsumoto K; Saito R; Motoki K; Sakai M; Chikamatsu N; Hagihara C; Hashiba M; Iwanaga T
J Pharmacol Exp Ther; 2019 Oct; 371(1):162-170. PubMed ID: 31371478
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]